Evidence map›Paper›PMID 31016321›Full record

ArticleThe Journal of infectious diseases2020

Large, Stable, Contemporary Interspecies Recombination Events in Circulating Human Herpes Simplex Viruses.

Amanda M Casto, Pavitra Roychoudhury, Hong Xie, Stacy Selke, Garrett A Perchetti, Haley Wofford, Meei-Li Huang, Georges M G M Verjans, Geoffrey S Gottlieb, Anna Wald and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Alphaherpesvirus Genomics: Past, Present and Future.Current issues in molecular biology · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 3 countries.

Amanda M CastoDepartments of Medicine, University of Washington, Seattle.
Pavitra RoychoudhuryLaboratory Medicine, University of Washington, Seattle.
Hong XieLaboratory Medicine, University of Washington, Seattle.
Stacy SelkeDepartments of Medicine, University of Washington, Seattle.
Garrett A PerchettiLaboratory Medicine, University of Washington, Seattle.
Haley WoffordDepartments of Medicine, University of Washington, Seattle.
Meei-Li HuangLaboratory Medicine, University of Washington, Seattle.
Georges M G M VerjansDepartment of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Geoffrey S GottliebDepartments of Medicine, University of Washington, Seattle.
Anna WaldDepartments of Medicine, University of Washington, Seattle.
Keith R JeromeLaboratory Medicine, University of Washington, Seattle.
David M KoelleDepartments of Medicine, University of Washington, Seattle.
Christine JohnstonDepartments of Medicine, University of Washington, Seattle.
Alexander L GreningerLaboratory Medicine, University of Washington, Seattle.
University of Washington · USUniversity of Veterinary Medicine Hannover, Foundation · DE

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
Improving Diagnosis, Treatment & Detection of Drug Resistance in HIV-2 InfectionR01AI120765 · NIAID · UNIVERSITY OF WASHINGTON · PI Geoffrey Scott Gottlieb · 2015 to 2026
$8.9M
Antiretroviral Therapy for HIV-2 Infection in SenegalR01AI060466 · NIAID · UNIVERSITY OF WASHINGTON · PI GOTTLIEB, GEOFFREY SCOTT · 2005 to 2014
$6.5M
Training Program in Infectious Diseases in the Immunocompromised HostT32AI118690 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BOECKH, MICHAEL J · 2016 to 2025
$4.0M
NIAID NIH HHS R01 AI060466NIAID NIH HHS R01 AI120765NIAID NIH HHS T32 AI007140NIAID NIH HHS T32 AI118690
6 · The paper itself

Abstract

backgroundThe ubiquitous human pathogens, herpes simplex virus (HSV)-1 and HSV-2, are distinct viral species that diverged approximately 6 million years ago. At least 4 small, ancient HSV-1 × HSV-2 interspecies recombination events have affected the HSV-2 genome, with recombinants and nonrecombinants at each locus circulating today. However, it is unknown whether interspecies recombination can affect other loci and whether new recombinants continue to be generated.

methodsUsing 255 newly sequenced and 230 existing HSV genome sequences, we comprehensively assessed interspecies recombination in HSV.

resultsOur findings show that the sizes and locations of interspecies recombination events in HSV-2 are significantly more variable than previously appreciated and that they can impact species-specific T-cell recognition of HSV.

conclusionsWe describe 2 large (>5 kb) recombination events, one of which arose in its current host, demonstrating that interspecies recombination continues to occur today. These results raise concerns about the use of live-attenuated HSV-2 vaccines in high HSV-1 prevalence areas.

Indexed as

DNA, ViralGenome, ViralHerpes SimplexHerpesvirus 1, HumanHerpesvirus 2, HumanHumansPhylogenyRecombination, GeneticSpecies SpecificityDNA, Viralgenomeherpes simplex virusphylogenyrecombinationT-cells

Identifiers

PMID31016321
PMCPMC7325804
OpenAlexW2940669288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.